Live Breaking News & Updates on Trinityj Bivalacqua

Stay updated with breaking news from Trinityj bivalacqua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cretostimogene Grenadenorepvec Confers High CR Rate in NMIBC

Preliminary findings from the phase 3 BOND-003 trial showed that treatment with cretostimogene grenadenorepvec led to sustained and durable complete responses and a tolerable safety profile in patients with high-risk non-muscle invasive bladder cancer who are unresponsive to Bacillus Calmette-Guerin. ....

United States , University Of Pennsylvania , Arthur Kuan , Trinityj Bivalacqua , Perelman Center , American Urological Association , Medicine Of The University Pennsylvania , Meeting Of The Society Urological Oncology , Bacillus Calmette Guerin , Annual Meeting , Urological Oncology , Advanced Medicine , Phase 3 Bond 003 , Cretostimogene Grenadenorepvec , Society Of Urological Oncology ,